Back to School: How biopharma can reboot drug development. Access exclusive analysis here

CoTherix postpones IPO

CoTherix (South San Francisco, Calif.) postponed its proposed IPO, citing market conditions.

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE